Get the app
US › Healthcare

BeyondSpring Inc (BYSI)

US · Healthcare · Biotechnology

$0.56-3.95%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$-849,000
EPS
$-0.02

Key statistics

Market cap
$23.0M
Forward P/E
10.5
P/B
5.38
Book value
$-0.86
EPS (TTM)
$-0.18
52-week high
$2.44
52-week low
$0.56
50-day MA
$0.72
200-day MA
$1.33
Beta
-0.21

Analyst view

with an average price target of $1.25.

Shareholding

Insiders
17.40%
Institutions
14.77%

Largest institutional holders

FundStake
Decheng Capital LLC9.24%
BlackRock Inc1.64%
Vanguard Capital Management, LLC1.52%
Geode Capital Management, LLC0.89%
State Street Corp0.56%
Vanguard Fiduciary Trust Co0.44%
UBS Group AG0.15%
Northern Trust Corp0.15%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BeyondSpring Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.